Pharmacytimes: Condition Center: Acute Coronary Syndrome Acute Coronary Syndrome en-us Fri, 20 Oct 2017 04:59:34 UTC Fri, 20 Oct 2017 04:59:34 UTC The Role of Rivaroxaban in Stable Cardiovascular Disease Rivaroxaban with or without aspirin was evaluated for the secondary prevention of cardiovascular outcomes 1:22 AM, Tue October 10, 2017 5 Lipid-Lowering Studies Pharmacists Should Know About A number of landmark clinical studies on lipid lowering and cardiovascular health have been published, shaping how patients are treated. 11:47 PM, Thu August 24, 2017 All That Is Old Becomes New Again: New Roles for Old, Antiplatelets in STEMI This article discusses the potential role of tirofiban as a complementary agent to the newer oral P2Y12 receptor blockers in STEMI patients. 1:22 AM, Thu August 10, 2017 Adherence to Statins after ACS: What's Your Baseline? Patients who experience acute coronary syndrome need high-intensity statin therapy.&nbsp; 7:00 AM, Fri April 21, 2017 Using Morphine in Acute Myocardial Infarction: A Potential Mistake? Morphine and Ticagrelor Drug Interaction 10:27 PM, Mon April 3, 2017 Health Groups Call for FDA to Ban All Flavored Tobacco Products &nbsp;<br /> Several public health and antismoking groups are urging the FDA to enforce more stringent regulations on the manufacturing of tobacco products&nbsp;by banning candy and fruit-flavored e-cigarettes and cigars.&nbsp; 10:55 AM, Tue March 21, 2017 Herbal Medications and Patients with Heart Disease: What to Discuss Herbal medications remain popular among this patient population group.&nbsp; 10:19 AM, Tue February 28, 2017 4 Essential Pharmacotherapy Findings from ESC Congress 2016 Many exciting clinical trial results are being presented at ESC Congress 2016 and published simultaneously this week. 11:18 PM, Tue August 30, 2016 Is Ticagrelor Superior to Clopidogrel in Real-World ACS Patients? Clinical trial data don't always reflect real-world experience. 11:37 PM, Sun August 14, 2016 Statin Use in HIV Patients Taking Protease Inhibitors HIV infection is a proinflammatory condition predisposing patients to arteriosclerosis, diabetes mellitus, dyslipidemia, and vascular thrombosis. 10:55 PM, Sun July 31, 2016 How Health-System Pharmacists Can Improve Adherence in Patients with Acute Coronary Syndrome At the ASHP 2016 Summer Meetings, Christopher Betz, PharmD, BCPS, FKSHP, FASHP, shared some of the ways pharmacists can use motivational interviewing to improve adherence in ACS patients. 10:36 PM, Tue July 26, 2016 What the Smoker's Paradox Means for ACS Patients A lifetime of smoking shortens life expectancy by a decade or more. 9:09 PM, Tue July 26, 2016 FDA Requests Additional Information for Aggrastat The FDA reviews Medicure Inc&acirc;&euro;&trade;s supplemental new drug application for Aggrastat. 7:00 AM, Thu July 21, 2016 Wearable Cardioverter Defibrillators: A Safety Net for ACS Patients Sudden cardiac arrest occurs 424,000 times outside of the hospital annually. 10:43 PM, Sun July 17, 2016 State Trends in Secondhand Smoke Laws Do you smoke?" is often the first question health care providers ask when patients experience symptoms suggestive of acute coronary syndrome. 8:59 AM, Tue June 28, 2016 Morphine for Myocardial Infarction: Pros and Cons Myocardial infarction is a painful condition with tightness, pressure, or squeezing pain in the chest for approximately 75% of patients who experience it. 8:49 AM, Wed June 22, 2016 Cardio-Cousins: Heart Failure, Atrial Fibrillation, and Acute Coronary Syndrome Cardiovascular disease accounts for 30% of all deaths worldwide, and it is not just 1 disease. 1:49 AM, Thu June 9, 2016 A Quick Summary of P2Y12 Inhibitor Interactions More than 1 million Americans have an acute coronary syndrome event annually, and more than 400,000 individuals die from ACS events each year. 9:38 PM, Tue June 7, 2016 PCSK9 Inhibitors: What Pharmacists Should Know This article highlights several key therapeutics areas for PCSK9 inhibitors that every pharmacist should know. 10:01 PM, Tue May 31, 2016 Female ACS Patients Face Greater Risks for Adverse Events After PCI Women with acute coronary syndrome are more likely than men to experience a major adverse cardiac event and bleeding 1 year after undergoing percutaneous coronary intervention. 1:22 AM, Fri May 27, 2016